Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
25.14
-1.19 (-4.52%)
At close: Apr 28, 2026, 4:00 PM EDT
25.17
+0.03 (0.12%)
After-hours: Apr 28, 2026, 5:28 PM EDT
Tango Therapeutics Market Cap
Tango Therapeutics has a market cap or net worth of $3.63 billion as of April 28, 2026. Its market cap has increased by 2,490.18% in one year.
Market Cap
3.63B
Enterprise Value
3.27B
1-Year Change
2,490.18%
Ranking
Category
Stock Price
$25.14
Market Cap Chart
Since April 20, 2021, Tango Therapeutics's market cap has increased from $156.31M to $3.63B, an increase of 2,219.97%. That is a compound annual growth rate of 87.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 3.80B | 218.28% |
| Dec 31, 2025 | 1.19B | 259.49% |
| Dec 31, 2024 | 331.92M | -67.13% |
| Dec 29, 2023 | 1.01B | 57.94% |
| Dec 30, 2022 | 639.29M | -33.25% |
| Dec 31, 2021 | 957.76M | 512.74% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Crinetics Pharmaceuticals | 4.01B |
| Viking Therapeutics | 3.80B |
| ACADIA Pharmaceuticals | 3.74B |
| Travere Therapeutics | 3.74B |
| Telix Pharmaceuticals | 3.61B |
| Oruka Therapeutics | 3.47B |
| NewAmsterdam Pharma Company | 3.42B |
| Edgewise Therapeutics | 3.39B |